The cost-effectiveness analysis of EGFR mutation test for management of advanced non-small cell lung cancer in Thailand.

e20636Background: EGFR mutation is the most important predictive factor for EGFR TKI in advanced NSCLC. Patients who EGFR mutant should received EGFR TKI either in 1st or later line of treatments. ...